Treatment of acute lymphoblastic leukemia in a second remission

Donald Pinkel, F. Leonard Johnson, E. Donnall Thomas, A. John Barrett, Brad H. Pollock, George R. Buchanan

Resultado de la investigación: Letterrevisión exhaustiva

4 Citas (Scopus)


To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type. . .

Idioma originalEnglish (US)
Páginas (desde-hasta)823-824
Número de páginas2
PublicaciónNew England Journal of Medicine
EstadoPublished - mar. 23 1995
Publicado de forma externa

ASJC Scopus subject areas

  • Medicine(all)


Profundice en los temas de investigación de 'Treatment of acute lymphoblastic leukemia in a second remission'. En conjunto forman una huella única.

Citar esto